Within the tumor-stromal microenvironment a disrupted balance between matrix metalloproteinases (MMPs) and their inhibitors compromises the integrity of the extracellular matrix and promotes malignancy. Tissue inhibitors of metalloproteinases (TIMPs) have been linked to tumor suppression in studies of genetically altered tissue culture cells and in analyses of clinical specimens in situ. We generated transgenic mice as a model system to test the relationship between TIMP-1 levels in a host organ and susceptibility to experimentally targeted metastasis. Ectopically overexpressed TIMP-1 in the brain resulted in a tissue microenvironment with elevated protein levels of this natural MMP inhibitor. Metastatic challenge provided by lacZ-tagged ®brosar-coma cells permitted high-resolution analysis of metastatic load and pattern. We found that elevated host TIMP-1 imposed resistance to experimental metastasis of ®brosarcoma: In TIMP-1 overexpressing mice, brain metastases were signi®cantly reduced by 75% compared to wild-type littermates. Our ®ndings demonstrate that ectopic TIMP-1 expression eciently exerts a suppressive eect on metastasizing tumor cells.
In recent years it has been increasingly appreciated that not only the tumor cells but also the host stroma is integral to progression of cancer (Liotta et al., 1980 (Liotta et al., , 1991 Basset et al., 1990; Mignatti and Rifkin, 1993; Vassalli et al., 1994) . The antioncogenic eects of secreted TIMPs have been shown by genetic modulation of TIMPs in tumor cells (Khokha et al., 1989 (Khokha et al., , 1992 DeClerck et al., 1992) , and postulated from clinical studies (Muller et al., 1995; Nuovo et al., 1995) .
It now remains to be tested if TIMPs will exert a similar tumor suppressive eect, when expressed within a host. Recently we demonstrated that early stages of viral-oncogene induced tumorigenesis were inhibited by TIMP-1 overexpression in transgenic mice (Martin et al., 1996) . Here, our objective was to examine the inhibitory eect of ectopic TIMP-1 expression in a transgenic host on the late stage of tumorigenesis, namely metastasis.
TIMP-1 overexpressing transgenic mice were generated by microinjecting the zygotes of C57BL/66SJL mice with an expression vector containing TIMP-1 cDNA under the transcriptional control of the murine metallothionein-1 promoter ( Figure 1a ). Founders were identi®ed and two lines, 277-34 and 277-35, were established by further breeding in the C57BL/6 background. RNA analysis revealed high constitutive expression of the TIMP-1 transgene in brain ( Figure  1a ) and other organs including pancreas, thymus and muscle. Endogenous TIMP-1 expression is normally very low or undetectable in murine brain (Leco et al., 1994) . Expression of the TIMP-1 transgene was observed without induction by metal and resulted in the synthesis of increased levels of TIMP-1 protein in the brain of transgene-positive (277-34T+ and 277-35T+) mice, when compared with transgene-negative (277-34T7 and 277-35T7) control littermates ( Figure  1b ). Although this reproducible and consistent increase of TIMP-1 protein was only about 2 ± 3-fold, all subsequent experiments were performed without exposure to heavy metal.
Since clinically brain is one of the most aicted sites of metastasis, we tested the potential anti-metastatic eect of elevated TIMP-1 in this organ. Littermates of the 277-34 lineage were genotyped and assigned to the TIMP-1 transgene positive or the negative wild type category, the latter being used as experimental control. Metastatic challenge was directed to the brain by left ventricular injection of the ®brosarcoma cell line FS/ L10, which is capable of producing metalloproteinases MMP-9 and MMP-2 (data not shown). This tumor line is syngeneic to the C57BL6 mouse strain and generates brain metastases with a 100% incidence (SanchezSweatman et al., 1996) .
All of our studies were conducted as double blind experiments. Metastasis was quanti®ed by histological analyses, which included counting of the metastatic foci and morphometric analysis of tumor burden, in random sections of hematoxylin/eosin-stained brain. TIMP-1 overexpressing mice displayed a signi®cant reduction in brain metastases compared to the wild type littermates, with a 43% decrease in tumor nodules per ®eld (2.0+0.41, n=22 versus 3.5+0.66, n=25; mean+s.e.m.; n=total mice group; P=0.05). Next we generated lacZ-tagged ®brosarcoma cells to facilitate image analysis, determine topographic distribution of the metastases, and provide an increased sensitivity of detection of the metastatic foci throughout the polymorphic brain tissue. lacZ-expressing FS/L10 cells were injected as before and subsequent X-Gal staining of whole organ mounts revealed the metastatic pattern and load on the outer and inner surfaces of the brain sections at high resolution. As illustrated, FS/L10-lacZ metastases colonized predominantly in the cortical and juxtacortical regions of the brain (Figure 2a ,b) in a perivascular fashion. It was macroscopically evident that metastases disseminated following cortical blood vessels. Individual multicellular tumor foci were counted on all surfaces of the dissected brain sections. This quanti®cation revealed that in TIMP-1 overexpressing mice the overall number of metastases was reduced to as low as 25% of those in wild type littermates (10.7+6.12, n=6 versus 40.6+4.05, n=8; mean+s.e.m.; P=0.001; Figure 2d ). This inhibitory eect was subsequently con®rmed under identical experimental conditions in the second independent transgenic line (277 ± 35), which also overexpressed TIMP-1 in brain and showed a 50% reduction in metastatic load compared to controls (Figure 2f) . Thus, the gain in brain TIMP-1 (Figure 1b Expression levels were determined without induction by metals. Methods: The EcoRI expression cassette was cloned downstream from the mouse metallothionein-1 promoter and upstream of the human growth hormone splice and termination signals (Khokha et al., 1992 ) and microinjected into zygotes (C57BL/66SJL) using standard techniques. Transgene-bearing founders were identi®ed by Southern analysis of DNA isolate from tail biopsies and two lines were established (277-34 and 277-35) . To characterize the organ speci®c TIMP-1 transgene expression in the line 277-34, 20 mg total RNA isolated from dierent organs were electrophoresed through an agarose-formaldehyde gel and blotted onto GeneScreen Plus (Dupont). The blot was sequentially probed with 32 P-dCTP labeled murine TIMP-1 or glyceraldehyde-6-phosphate dehydrogenase (GAPDH) cDNA probes (labeled with Stratagene Prime-It Kit) and then subjected to autoradiography. (b) TIMP-1 protein levels in TIMP-1 transgene-positive mice and transgene-negative littermates detected by Western blotting using sheep anti-mouse TIMP-1 antibody. Methods: To assess the TIMP-1 protein levels, brain tissue was homogenized in protein isolation buer (1% Triton-X-100, 500 mM Tris-HCI pH 7.6, 200 mM NaCl, 10 mM CaC1 2 ) and samples were centrifuged. Protein content in the supernatant was determined using Bradford reagent (Biorad). Fifty micrograms of protein were electrophoresed through a 10% polyacrylamide SDS gel and electroblotted onto Hybond-N (Amersham) using a Mini Trans-Blot system (Biorad). Blots were blocked with 5% powdered milk in Tris-buered saline, 0.05% Tween 20 (TTBS) and subsequently incubated with polyclonal sheep anti-murine TIMP-1 antibodies (Martin et al. 1996) . Unbound antibody was removed by washing with TTBS, the blots were incubated with peroxidase-conjugated anti-sheep antibodies and developed with ECL chemiluminescence reagents (Amersham). Supernatant of baculovirus-infected SF 158 cells expressing recombinant TIMP-1 (rTIMP-1) was used as a positive control. Following autoradiography, blots were stained with amido black (Biorad) to con®rm equivalent loading and transfer of each sample Price et al., 1987) . The clones FS/L10-lacZ5 and FS/L10-lacZ6 were chosen after comparing several independent lacZ expressing clones to the parental line, with respect to their metastatic capacity and protease production (data not shown). All cell lines were maintained in RPMI medium supplemented with 10% fetal calf serum, 2 mM Lglutamine, 10 mM HEPES, 50 mg/ml streptomycin and 50 U/ml penicillin. Cells were removed from the tissue culture dish by incubation in PBS containing 0.0 1 M EDTA, washed and resuspended in PBS. Mice were anesthetized and 100 ml PBS continuing 15 cells were injected into the left ventricle of the heart, as described previously . All subsequent evaluations were performed as double blind experiments, and only the animals with successful injections were included in the study. Eighteen days after tumor cell inoculation, brains were removed and ®xed for 90 min at 48C in phosphate-buered 2% formaldehyde/0.2% glutaraldehyde and then frontally cross-sectioned into ®ve regions as listed. The tissue was further ®xed for 30 min to allow ®xation of newly exposed surfaces and subsequently washed in ice-cold PBS and incubated for 12 h in X-Gal solution (Price et al., 1987) . Metastases were counted using a Stereomicroscope and designated as small (5500 mm) or big (4500 mm) with the aid of an ocular micrometer. Alternatively, the tissue was paran-embedded, sectioned, hematoxylin/eosin-stained and analysed with light microscopy. All animal experiments were done using approved protocols under the guidelines of Canadian Council of Animal Care. Student t-test was used to assess statistical signi®cance. Values were considered signi®cant if P50.05
TIMP-1 inhibition of experimental brain metastasis A Kru Èger et al signi®cant inhibition of brain-targeted ®brosarcoma metastasis. Further, since metallothionein-1 promoterdirected transgenes can be expressed in most regions of the brain (D'Ercole et al., 1994) , we examined and found that the metastasis-inhibitory eect of elevated host TIMP-1 protein existed throughout the ®ve dierent regions of the brain, being statistically signi®cant in all regions except the cerebellum ( Figure  2e ). As well as reducing the absolute number of metastases, a smaller proportion of the metastatic foci that appeared in TIMP-1 overexpressing brains expanded beyond a diameter of 500 mm compared to the foci in wild type brains, when measured by an ocular micrometer (16.3%+3.1 versus 31.3%+3.5; mean+s.e.m.). Previously we have shown that genetically modulated TIMP-1 overexpressing melanoma cells were growth inhibited in vivo (Koop et al., 1995) , and that oncogene-induced hepatocellular carcinoma development was inhibited in transgenic mice overexpressing hepatic TIMP-1 protein (Martin et al., 1996) . Here, in a genetically altered host organ, the gain of TIMP-1 suppressed both the number of metastases and the extent of their growth. The reduced metastatic load could result from a failure of ®brosarcoma cells to extravasate from the blood capillaries into TIMP-1 overexpressing brain tissue or from the inability to grow after extravasation in the altered organ microenvironment. The high resolution aorded by lacZ expression revealed sites of extravasation from blood vessels and migration into the perivascular tissue (Figure 2c ) in whole organ mounts of both TIMP-1 overexpressing and wild type groups. Evidence that extravasation was not blocked was further documented by histological analysis of reticulin-speci®c silver staining of brain sections. Microscopically, disruption of the annular pattern of vascular reticulin was observed equally in both experimental groups, in areas where the tumor cells were present (data not shown). These events seen in both TIMP-1 overexpressing and control brains make the direct inhibition of extravasation by host TIMP-1 unlikely. Therefore, growth inhibition of micrometastases by elevated host TIMP-1 expression remains a strong possibility. Our ongoing studies will determine whether reduced angiogenesis or increased apoptosis of extravasated tumor cells are aected by high TIMP-1 levels in the brain. Both of these processes are at least in part dependent on the host extracellular matrix (Liotta et al., 1991; Folkman and Shing, 1992; Boudreau et al., 1995) .
Our metastasis model of TIMP-1 transgenic host and lacZ-tagged tumor cells demonstrates a strong relationship between the expression of host-derived TIMP-1 in the brain and the eciency with which ®brosarcoma cells colonize this target organ. Tumor cells disrupt the ECM by the overexpression of proteinases. Preservation of the proteinase: inhibitor balance within the host tissue due to the microenvironment factor TIMP-1, which is capable of inhibiting all matrix metalloproteinases, will counteract ECM disruption. In this study, host TIMP-1 overexpression imposed resistance to a metastatic challenge as both the tumor number and growth were aected with a subsequent signi®cant reduction of metastatic burden in the brain. In conclusion, multiple stages of tumorigenesis including tumor initiation of hepatocellular carcinoma as well as ®brosarcoma metastasis can possibly be inhibited by TIMP-1. Our observations encourage investigation of this eect on other malignancies and the consideration of novel therapies including host TIMP-inducing biological response modi®ers (Edwards et al., 1987; Roeb et al., 1994; Bugno et al., 1995) or gene therapy, designed to establish a tumor-protective microenvironment.
